Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 20, 2026
TickeronGET DAILY SIGNALS
AEHR vs TER: Contrasting a Focused AI Test Play with a Diversified Leader

AEHR vs TER: Contrasting a Focused AI Test Play with a Diversified Leader

Key Takeaways

  • AEHR is a small-cap, high-growth play on AI semiconductor test and burn-in, while TER is a large, diversified, and consistently profitable automated test equipment (ATE) leader.
  • Both stocks are riding powerful AI-driven semiconductor demand, but their risk profiles differ sharply: AEHR is more volatile and trades at a premium valuation, while TER offers broader revenue diversification and a steadier earnings base.
  • Tickeron AI Verdict: TER — Teradyne is the ticker of choice based on trend consistency, diversification, profitability, and relative stability.
  • AEHR recently swung to profitability and raised guidance on record bookings, while TER reported roughly 70% year-over-year revenue growth led by AI and record memory test sales.
  • For more context, explore AEHR Major News and AEHR Today's Price Move, plus TER Major News and TER Today's Price Move.
  • To see how AI-powered strategies are positioning across the market, explore Trending AI Robots.

Why This Comparison Matters

Both AEHR and TER sit at the center of the artificial intelligence infrastructure buildout, yet they occupy very different positions within the semiconductor equipment ecosystem. Aehr Test Systems is a focused, fast-growing supplier of wafer-level and package-level burn-in and test systems, while Teradyne is an established automated test equipment and robotics powerhouse. This stock comparison is relevant for traders and investors seeking to weigh a high-beta, high-growth story against a scaled, diversified market leader. By examining relative performance, growth drivers, and market positioning, readers can better assess which profile aligns with their own risk tolerance and time horizon. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

AEHR Overview and Recent Performance

AEHR, or Aehr Test Systems, designs and sells full-wafer contact and burn-in test systems used to improve the reliability of semiconductors, with particular strength in wafer-level burn-in (WLBI) for AI processors and related chips. In recent weeks the company delivered a standout fiscal quarter, roughly tripling revenue year over year and swinging to a net profit. Bookings exceeded revenue, backlog expanded, and management raised its full-year revenue outlook to around $150 million, citing accelerating demand for its AI semiconductor test and burn-in solutions.

That fundamental momentum has been paired with extreme price volatility. Shares have posted a substantial gain over the trailing 12 months and year to date, yet recent market activity has been sharp, with significant drawdowns followed by large single-day rallies around earnings. Sentiment remains divided: bulls emphasize record bookings and a broadening customer base, while bears point to a steep price-to-sales multiple and a still-early profitability profile that leaves the stock sensitive to shifts in AI capital spending. From what I see, the volatility here is worth monitoring closely.

TER Overview and Recent Performance

TER, or Teradyne, is a leading provider of automated test equipment (ATE) used to test semiconductors and electronics, complemented by a robotics segment that includes collaborative and mobile robots for manufacturing and warehousing. Recent results have been strong, with revenue rising roughly 70% year over year as AI-related demand drove more than half of sales. Memory test reached a record level, and the company continues to invest in new products aimed at next-generation AI devices.

Like AEHR, Teradyne's share price has experienced meaningful pullbacks from recent highs, reflecting broader semiconductor-sector volatility and investor debate over the durability of AI spending. However, Teradyne's larger scale, diversified end markets, recurring profitability, and a modest dividend provide a different risk profile. Analysts have highlighted both the breadth of its growth drivers and some margin compression tied to product mix, leaving the stock balanced between continued upside and valuation caution.

Head-to-Head Comparison

The clearest contrast between these two names is scale and maturity. TER is a multi-billion-dollar, consistently profitable enterprise with diversified revenue across semiconductor test, system test, and robotics, giving it multiple growth levers and a steadier earnings base. AEHR is far smaller and more concentrated, with its fortunes tightly linked to wafer-level burn-in adoption by a relatively small group of AI processor customers — a setup that can deliver explosive growth but also pronounced volatility.

On momentum, both stocks have benefited from the same AI infrastructure theme, but their paths differ. AEHR's recent quarter showed accelerating revenue and a turn to profitability, while Teradyne's growth, though large in absolute terms, has shown some quarter-to-quarter moderation alongside mild margin pressure from product mix. On valuation, AEHR trades at a premium price-to-sales multiple that leaves little room for error, whereas Teradyne's more moderate multiple and consistent earnings provide greater downside cushion. Risk factors also diverge: customer concentration and early-stage profitability weigh on AEHR, while Teradyne faces competitive pressure and cyclical exposure across a broader test market. I’m watching this closely for how the relative stability plays out.

Tickeron AI Verdict

Based on observable factors including trend consistency, stability, diversification, and profitability, Tickeron's AI would currently favor TER in this comparison. Teradyne's combination of sustained revenue growth, a record memory test contribution, recurring profitability, and a more diversified business model tends to produce a steadier and more reliable trend profile than AEHR's higher-volatility, higher-valuation growth story. While AEHR offers compelling upside tied to its accelerating burn-in adoption, its concentrated customer base and premium valuation introduce greater variability. This analysis uses probabilistic language rather than definitive claims and is not a substitute for independent research.

Exploring Tickeron AI Trading Bots

In my own research, I often turn to Tickeron’s AI Trading Bots to test systematic approaches across volatile names like these. The platform offers a range of strategies with performance records and covered securities, helping users match bots to their preferred timeframes and risk levels. It is a useful way to compare options without committing capital upfront.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AEHR, TER

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AEHR sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for AEHR moved below the 200-day moving average on November 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 73 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for AEHR entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.

Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 46.26B. The market cap for tickers in the group ranges from 310.74K to 665.22B. ASMLF holds the highest valuation in this group at 665.22B. The lowest valued company is SMTK at 310.74K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -7%. For the same Industry, the average monthly price growth was -20%, and the average quarterly price growth was -41%. ASYS experienced the highest price growth at -1%, while AEHR experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 24% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 44
Price Growth Rating: 63
SMR Rating: 71
Profit Risk Rating: 78
Seasonality Score: 27 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of burn-in and test equipment for semiconductor manufacturing

Industry ElectronicProductionEquipment

Industry
Electronic Production Equipment
Address
400 Kato Terrace
Phone
+1 510 623-9400
Employees
138
Web
https://www.aehr.com
Interact to see
Advertisement
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.